When making treatment decisions regarding PrEP, it is important that clinicians consider the long-term impact on bone health, lipids, and renal dysfunction. This includes the need for education on data comparing the safety and efficacy of emtricitabine and tenofovir disoproxil fumarate (F/TDF) and emtricitabine and tenofovir alafenamide (F/TAF) in order to facilitate data-driven decisions about PrEP.
This CME Outfitters webcast will feature expert faculty discussing clinical trial outcomes and how to apply them to treatment decision-making in order to improve clinical knowledge, confidence, and performance for utilizing PrEP.
At the end of this CME/CE activity, participants should be able to apply clinical trial outcomes to treatment decision-making, considering long-term impact on bone health, lipids, and renal dysfunction.
The following learning objectives pertain only to those requesting CNE or CPE credit: Describe how to apply clinical trial outcomes to treatment decision-making, considering long-term impact on bone health, lipids, and renal dysfunction.
Supported by an educational grant from Gilead Sciences, Inc.
Physicians, PAs, nurse practitioners, nurses, and pharmacists.
It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and mitigated any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process.
Dr. Wohl reports that he receives research support and grants from Gilead Sciences, Inc.; Merck & Co., Inc.; and ViiV Healthcare. He is on the advisory committee for Gilead Sciences, Inc.; Janssen Pharmaceuticals, Inc.; Merck & Co., Inc.; and ViiV Healthcare.
Dr. Savoy has no disclosures to report.
Disclosures were obtained from the CME Outfitters, LLC staff: No disclosures to report.
Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.
Call us at (877) CME-PROS or (877) 263-7767.